A drug company accused of fraudulently promoting the antipsychotic Risperdal for use in Texas’s Medicaid system has settled a state Attorney General’s lawsuit for $158 million. The AG’s office, one of several across the country to sue Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson) for fraudulent marketing, had sought…